Vaccines, blood, antisera, toxins and cultures in   Indonesia

Exports In 2022, Indonesia exported $137M in Vaccines, blood, antisera, toxins and cultures, making it the 38th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 222nd most exported product in Indonesia. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Indonesia are: India ($57.3M), Nigeria ($13.6M), Pakistan ($9.89M), Egypt ($6.51M), and Vietnam ($4.49M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Indonesia between 2021 and 2022 were India ($3.96M), South Korea ($3.88M), and Pakistan ($2.15M).

Imports In 2022, Indonesia imported $669M in Vaccines, blood, antisera, toxins and cultures, becoming the 48th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 70th most imported product in Indonesia. Indonesia imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($139M), China ($91.7M), India ($63.1M), Germany ($51.8M), and France ($48.5M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Indonesia between 2021 and 2022 were Ireland ($14.2M), Argentina ($9.9M), and India ($9.29M).